SCINTIPHARMA, Inc. is a privately held company focused on problem solving in the field of pharmaceutical dosage form development. The company's main objective is to provide services to the pharmaceutical industry for the optimization of drug delivery systems. The primary mission is improved delivery of currently marketed and potentially marketable therapeutic agents in the gastrointestinal tract as well as other routes such as nasal, ocular, inhalation, or rectal.
Some of the world's principal experts in pharmaceutical drug delivery are available for consultation. Scintipharma staff received their formal training from and continue to consult the innovating pioneer of gamma scintigraphy in pharmaceutical research. Pharmaceutical formulation and gamma scintigraphic studies have been performed for many of the pharmaceutical industries leading companies.
What is Gamma Scintigraphy?
Gamma scintigraphy is a technique whereby the transit of a dosage form through its intended site of delivery can be non-invasively imaged in vivo via the judicious introduction of an appropriate short lived gamma emitting radioisotope. The observed transit of the dosage form can then be correlated with the rate and extent of drug absorption. Information such as the site of disintegration or dispersion can also be obtained. Assistance in product development as well as testing of finished products for corporate sponsors are commonly performed.
Scintipharma, Inc. has not received any reviews.
Scintipharma, Inc. has not received any endorsements.